{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:59:04Z","timestamp":1784116744549,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.atherosclerosis.2011.04.040","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T21:14:33Z","timestamp":1304802873000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals"],"prefix":"10.1016","volume":"218","author":[{"given":"Takamitsu","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ei","family":"Obata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumasa","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Mishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Kugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0005","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0010","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jacc.2007.07.045","article-title":"Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease","volume":"50","author":"Mudd","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.amjcard.2007.11.046","article-title":"Relative atherogenicity and predictive value of non\u2013high-density lipoprotein cholesterol for coronary heart disease","volume":"101","author":"Miller","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"Arsenault","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/ATVBAHA.108.181735","article-title":"Prognostic utility of apoB\/AI, total cholesterol\/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22","volume":"29","author":"Ray","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0030","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00041433-200012000-00008","article-title":"Remnant lipoproteins as therapeutic targets","volume":"11","author":"Havel","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0045","doi-asserted-by":"crossref","first-page":"41L","DOI":"10.1016\/j.amjcard.2008.09.074","article-title":"Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering","volume":"102","author":"Jones","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2008.04.052","volume":"52","author":"Ballantyne","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0055","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0026-0495(83)90112-9","article-title":"Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects","volume":"32","author":"Nestel","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0065","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.97.25.2519","article-title":"Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries","volume":"97","author":"Kugiyama","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0070","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2003.09.074","article-title":"Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus","volume":"43","author":"Fukushima","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2008.03.018","article-title":"High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis","volume":"202","author":"Nakamura","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0080","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0002-9149(01)02115-4","article-title":"Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease","volume":"88","author":"Fukushima","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2005.01.012","article-title":"Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome","volume":"181","author":"Nakamura","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/sim.1310","article-title":"Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation","volume":"22","author":"Royston","year":"2003","journal-title":"Stat Med"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0095","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/01.CIR.0000125278.58527.F3","article-title":"Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype","volume":"109","author":"Twickler","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0140","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1161\/01.CIR.102.18.2284","article-title":"AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association","volume":"102","author":"Scientific Statement AHA","year":"2000","journal-title":"Circulation"},{"issue":"Suppl. A","key":"10.1016\/j.atherosclerosis.2011.04.040_bib0105","first-page":"A40","article-title":"Triglyceride-rich lipoproteins and progression of atherosclerosis","volume":"19","author":"Hodis","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.102.6.670","article-title":"Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism","volume":"102","author":"Doi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0115","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.ATV.0000173310.85845.7b","article-title":"Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu heart study","volume":"25","author":"Imke","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(00)00484-6","article-title":"Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study","volume":"154","author":"McNamara","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/jc.2006-1973","article-title":"High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia","volume":"92","author":"de Graaf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/clinchem\/37.8.1394","article-title":"Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formula","volume":"37","author":"Sent\u00ed","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2011.04.040_bib0135","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.CIR.88.6.2762","article-title":"Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events","volume":"88","author":"Phillips","year":"1993","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011003868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011003868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:21:41Z","timestamp":1762186901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011003868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0021915011003868"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.04.040","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}